Label: DOCUSATE SODIUM- docusate sodium capsule

  • NDC Code(s): 55289-493-14, 55289-493-30, 55289-493-60, 55289-493-90, view more
    55289-493-93
  • Packager: PD-Rx Pharmaceuticals, Inc.
  • Category: HUMAN OTC DRUG LABEL
  • DEA Schedule: None
  • Marketing Status: OTC monograph not final

DISCLAIMER: Most OTC drugs are not reviewed and approved by FDA, however they may be marketed if they comply with applicable regulations and policies. FDA has not evaluated whether this product complies.

Drug Label Information

Updated June 17, 2019

If you are a consumer or patient please visit this version.

  • Active ingredient (in each softgel)

    Docusate sodium 100 mg

    Close
  • Purpose

    Stool softener

    Close
  • Uses

    • relieves occasional constipation (irregularity)
    • results usually occurs 1 to 3 days after the first dose
    Close
  • Warnings


    Do not use

    Do not use if you are currently taking mineral oil, unless directed bya doctor

    Ask a doctor before use if you

    • stomach pain, nausea or vomiting
    • have noticed a sudden change in bowel habits that last over 2 weeks

    Stop use and ask a doctor if

    • you have rectal bleeding
    • you fail to have a bowel movement after use

    you need to use a stool softner laxative for more than 1 week

    If pregnant or breast-feeding,

    ask a health professional before use.

    Keep out of reach of children.

    In case of overdose, get medical help or contact a Poison Control Center right away.

    Close
  • Directions

    • do not exceed recommended dose
    adults and children over 12 years and older                        
    take 1-3 softgels daily
    children 2 to 12 years of age
    take 1 softgel daily
    children under 2 years
    ask a doctor
    Close
  • Other information

    • Each capsule contains sodium 6mg
    • store at room temperature 15 o to 30 oC (59 o to 86 oF)
    • protect from moisture
    Close
  • Inactive ingredients: FD&C Red #33,Edible Ink,FD&C Red #40,FD&C Yellow #6, Gelatin, Glycerin, Polyethylene Glycol, Purified Water, Sorbitol Special.
  • Questions?

    Adverse drug event call: (866) 562-2756

    Close
  • HOW SUPPLIED

    Supplied in bottles of 14, 30, 60, 90 and 180 softgels.

    Close
  • Principal Display Panel

    *Compare to the active ingredient of Colace®

    Docusate Sodium

    Stool Softener

    100 mg each

    IMAGE

    Close
  • INGREDIENTS AND APPEARANCE
    DOCUSATE SODIUM 
    docusate sodium capsule
    Product Information
    Product Type HUMAN OTC DRUG Item Code (Source) NDC:55289-493
    Route of Administration ORAL
    Active Ingredient/Active Moiety
    Ingredient Name Basis of Strength Strength
    DOCUSATE SODIUM (UNII: F05Q2T2JA0) (DOCUSATE - UNII:M7P27195AG) DOCUSATE SODIUM 100 mg
    Inactive Ingredients
    Ingredient Name Strength
    D&C YELLOW NO. 10 (UNII: 35SW5USQ3G)  
    FD&C RED NO. 40 (UNII: WZB9127XOA)  
    GELATIN (UNII: 2G86QN327L)  
    GLYCERIN (UNII: PDC6A3C0OX)  
    POLYETHYLENE GLYCOL (UNII: 3WJQ0SDW1A)  
    PROPYLENE GLYCOL (UNII: 6DC9Q167V3)  
    SORBITOL (UNII: 506T60A25R)  
    Product Characteristics
    Color red (Two-toned- white and clear red) Score no score
    Shape OVAL Size 12mm
    Flavor Imprint Code SC02
    Contains     
    Packaging
    # Item Code Package Description Marketing Start Date Marketing End Date
    1 NDC:55289-493-14 14 in 1 BOTTLE, PLASTIC; Type 0: Not a Combination Product 01/12/2018
    2 NDC:55289-493-30 30 in 1 BOTTLE, PLASTIC; Type 0: Not a Combination Product 01/12/2018
    3 NDC:55289-493-60 60 in 1 BOTTLE, PLASTIC; Type 0: Not a Combination Product 01/12/2018
    4 NDC:55289-493-90 90 in 1 BOTTLE, PLASTIC; Type 0: Not a Combination Product 01/12/2018
    5 NDC:55289-493-93 180 in 1 BOTTLE, PLASTIC; Type 0: Not a Combination Product 01/12/2018
    Marketing Information
    Marketing Category Application Number or Monograph Citation Marketing Start Date Marketing End Date
    OTC monograph not final part334 01/12/2018 01/31/2038
    Labeler - PD-Rx Pharmaceuticals, Inc. (156893695)
    Registrant - PD-Rx Pharmaceuticals, Inc. (156893695)
    Establishment
    Name Address ID/FEI Business Operations
    PD-Rx Pharmaceuticals, Inc. 156893695 repack(55289-493)
    Close